BIOMAT Database Logo BIOMAT Database Logo

Role of oxidized low-density lipoprotein in the atherosclerosis of uremia. 2001

T B Drüeke, and T Nguyen Khoa, and Z A Massy, and V Witko-Sarsat, and B Lacour, and B Descamps-Latscha
Inserm U507, Division of Nephrology, and Biochemistry Laboratory A, Necker Hospital, Paris, France. drueke@necker.fr

Lipoprotein oxidation is involved in the genesis of atherosclerosis. In chronic renal failure (CRF), oxidative stress is enhanced because of an imbalance between pro-oxidant and antioxidant systems. Oxidative modifications of low-density lipoproteins (LDLs) occur not only at the level of lipid moiety, but also of protein moiety. We have shown that oxidation of LDL by hypochlorous acid (HOCl) in vitro, reflecting increased myeloperoxidase activity in vivo, leads to modifications of apoliproteins such that the latter in turn are capable of triggering macrophage nicotinamide adenine dinucleotide phosphate-oxidase activation. These oxidative changes of LDL protein moiety, if shown to occur to a significant extent in uremic patients in vivo, may represent an important alternative pathway in the pathogenesis of atheromatous lesions.

UI MeSH Term Description Entries
D006997 Hypochlorous Acid An oxyacid of chlorine (HClO) containing monovalent chlorine that acts as an oxidizing or reducing agent. Hypochlorite,Hypochlorous Acids
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001161 Arteriosclerosis Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries. Arterioscleroses
D014511 Uremia A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms. Uremias
D015227 Lipid Peroxidation Peroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor. Lipid Peroxidations,Peroxidation, Lipid,Peroxidations, Lipid
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

T B Drüeke, and T Nguyen Khoa, and Z A Massy, and V Witko-Sarsat, and B Lacour, and B Descamps-Latscha
Oxidized low-density lipoprotein and atherosclerosis.
December 2010, Arteriosclerosis, thrombosis, and vascular biology,
T B Drüeke, and T Nguyen Khoa, and Z A Massy, and V Witko-Sarsat, and B Lacour, and B Descamps-Latscha
Oxidized low-density lipoprotein and atherosclerosis.
January 1996, International journal of clinical & laboratory research,
T B Drüeke, and T Nguyen Khoa, and Z A Massy, and V Witko-Sarsat, and B Lacour, and B Descamps-Latscha
Oxidized low-density lipoprotein biomarkers in atherosclerosis.
January 2006, Current atherosclerosis reports,
T B Drüeke, and T Nguyen Khoa, and Z A Massy, and V Witko-Sarsat, and B Lacour, and B Descamps-Latscha
The role of oxidized low density lipoprotein in the pathogenesis of atherosclerosis.
August 1990, European heart journal,
T B Drüeke, and T Nguyen Khoa, and Z A Massy, and V Witko-Sarsat, and B Lacour, and B Descamps-Latscha
Oxidized low density lipoprotein, stem cells, and atherosclerosis.
July 2012, Lipids in health and disease,
T B Drüeke, and T Nguyen Khoa, and Z A Massy, and V Witko-Sarsat, and B Lacour, and B Descamps-Latscha
The lectin-like oxidized low-density lipoprotein receptor and its role in atherosclerosis.
March 2005, Current atherosclerosis reports,
T B Drüeke, and T Nguyen Khoa, and Z A Massy, and V Witko-Sarsat, and B Lacour, and B Descamps-Latscha
Oxidized low-density lipoprotein regulates macrophage polarization in atherosclerosis.
July 2023, International immunopharmacology,
T B Drüeke, and T Nguyen Khoa, and Z A Massy, and V Witko-Sarsat, and B Lacour, and B Descamps-Latscha
Mechanistic Insights into the Oxidized Low-Density Lipoprotein-Induced Atherosclerosis.
January 2020, Oxidative medicine and cellular longevity,
T B Drüeke, and T Nguyen Khoa, and Z A Massy, and V Witko-Sarsat, and B Lacour, and B Descamps-Latscha
Role of oxidized low density lipoprotein in atherogenesis.
December 1991, The Journal of clinical investigation,
T B Drüeke, and T Nguyen Khoa, and Z A Massy, and V Witko-Sarsat, and B Lacour, and B Descamps-Latscha
Role of oxidized low density lipoprotein in atherogenesis.
January 1992, Progress in lipid research,
Copied contents to your clipboard!